1. |
Concordance: just another version of compliance? |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
Telithromycin potentially cost saving in patients with AECB |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 3-4
L Hunt,
Preview
|
|
摘要:
Chronic bronchitis is a highly prevalent disease affecting more than 14 million individuals in the US alone. Patients with chronic bronchitis frequently experience acute exacerbations of the condition, the clinical management of which confers a major clinical and economic burden on healthcare systems. Total healthcare costs associated with acute exacerbations of chronic bronchitis (AECB) have been estimated to cost $US1.7 billion annually in the US, with hospitalisation accounting for the largest share of this cost. Investigators from the US and Canada found that telithromycin has the potential to have a major effect on the cost of AECB in the US, and they presented their results at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) [Chicago, US; September 2003].1
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
Supplemental recommendations for the use of intranasally administered trivalent live attenuated influenza virus vaccine ['FluMist'] have been released by the ACIP,* |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
Sedentary older adults who increase their physical activity can substantially reduce their annual medical costs, |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Computerised prescribing intervention successful |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Employers rate DM highly for cost containment |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
Migraine affects an estimated 5.85 million individuals aged 16−65 years in the UK, resulting in > 190 000 migraine attacks per day and around 25 million lost work- or schooldays per year, |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
Short-course beclomethasone enhances QOL in asthma |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
The Canadian government hopes to exempt generic forms of drugs for the treatment of AIDS from patent laws by the end of the year, |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Thalidomide prescribed off-label by physicians in Japan |
|
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 434,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|